These new recommendations, twice as long as those of 2001, will integrate significant advances in rresearch and clinical practices, while maintaining certain fundamental principles.
The constants: first-line psychotherapy
As in 2001, psychotherapy remains the main approach to treating borderline personality disorder (BPD). No medications are specifically approved for this condition, although some treatments may be used to manage specific symptoms.
The diagnostic criteria, initially defined in the DSM-III in 1980, remain unchanged. However, the 2025 guidelines will likely recognize a move towards a dimensional definition of the disorder, which takes into account the degree of severity and the impact on the patient.
Developments: a more optimistic prognosis and diversified approaches
One of the main changes is a more nuanced understanding of the evolution of BPD. While the 2001 edition considered cure as an unrealistic goal, recent studies show significantly improved remission and cure rates.
Additionally, the new recommendations will expand the range of psychotherapeutic approaches studied, beyond behavioral therapy…
Read more
Health
Canada
Related News :